Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
Specializing in regenerative tissue medicine, L&C BIO Co., Ltd. operates as a dedicated research and development enterprise. The company's diverse product range encompasses human tissue products, various medical devices, and a selection of cosmetic solutions. Established in 2011, this firm is headquartered in Seongnam, South Korea.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EBITD.
Target Price
The average target price of 290650.KQ is 102397 and suggests 65.2% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation